Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.0300 (-6%) ($15.0300 - $16.1500) on Fri. Jan. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 42 | Latest Price | $15.0300(-6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.8% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) ARKK(48%) IWO(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.835% in a week (0% probabilities). VXX(-36%) VIXM(-36%) TLT(-12%) UNG(-7%) UUP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | 0 () | Intraday Trend | -6.5% | | | |
|
Resistance Level | $16.34 | 5 Day Moving Average | $16.15(-6.93%) | 10 Day Moving Average | $16.58(-9.35%) | 20 Day Moving Average | $16.34(-8.02%) | To recent high | -15.5% | To recent low | 38% | Market Cap | $1.117b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |